BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 35299730)

  • 21. Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5.
    Abedalthagafi MS; Merrill PH; Bi WL; Jones RT; Listewnik ML; Ramkissoon SH; Thorner AR; Dunn IF; Beroukhim R; Alexander BM; Brastianos PK; Francis JM; Folkerth RD; Ligon KL; Van Hummelen P; Ligon AH; Santagata S
    Oncotarget; 2014 Nov; 5(21):10596-606. PubMed ID: 25347344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
    Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
    BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
    Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
    Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meningiomas - transition from traditional histological grading to molecular profiling in WHO CNS5: A Review.
    Goyal-Honavar A; Jayachandran R; Chacko G
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S83-S93. PubMed ID: 35562138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic markers of recurrence risk in atypical meningioma following gross total resection.
    Vaubel RA; Kumar R; Weiskittel TM; Jenkins S; Dasari S; Uhm JH; Lachance DH; Brown PD; Van Gompel JJ; Jenkins RB; Kipp BR; Sukov WR; Giannini C; Johnson DR; Raghunathan A
    Neurooncol Adv; 2023; 5(1):vdad004. PubMed ID: 36845294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular alterations in meningioma: prognostic and therapeutic perspectives.
    Birzu C; Peyre M; Sahm F
    Curr Opin Oncol; 2020 Nov; 32(6):613-622. PubMed ID: 32890025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in Central Nervous System Tumor Classification.
    Malta TM; Snyder J; Noushmehr H; Castro AV
    Adv Exp Med Biol; 2023; 1416():121-135. PubMed ID: 37432624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classification.
    Deng MY; Hinz F; Maas SLN; Anil G; Sievers P; Conde-Lopez C; Lischalk J; Rauh S; Eichkorn T; Regnery S; Bauer L; Held T; Meixner E; Lang K; Hörner-Rieber J; Herfarth K; Jones D; Pfister SM; Jungk C; Unterberg A; Wick W; von Deimling A; Debus J; Sahm F; König L
    Neurooncol Adv; 2023; 5(1):vdad059. PubMed ID: 37293256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression.
    Goutagny S; Nault JC; Mallet M; Henin D; Rossi JZ; Kalamarides M
    Brain Pathol; 2014 Mar; 24(2):184-9. PubMed ID: 24261697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
    Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
    Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular biological determinations of meningioma progression and recurrence.
    Linsler S; Kraemer D; Driess C; Oertel J; Kammers K; Rahnenführer J; Ketter R; Urbschat S
    PLoS One; 2014; 9(4):e94987. PubMed ID: 24722350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TERT promoter mutations in primary and secondary WHO grade III meningioma.
    Maier AD; Stenman A; Svahn F; Mirian C; Bartek J; Juhler M; Zedenius J; Broholm H; Mathiesen T
    Brain Pathol; 2021 Jan; 31(1):61-69. PubMed ID: 32805769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA methylation profiling of a lipomatous meningioma: illustrative case.
    Patel Z; Wang JZ; Merali Z; Patil V; Nassiri F; Wei Q; Sosa J; Coire C; Zadeh G
    J Neurosurg Case Lessons; 2023 Feb; 5(6):. PubMed ID: 36748749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methylation provides diagnostic value for meningioma recurrence in clinical practice.
    Shen E; Leclair NK; Herlth K; Soucy M; Renzette N; Zhuo X; Kelly K; Omerza G; Onyiuke H; McNeill I; Wolansky L; Becker K; Li L; Wu Q; Bulsara KR
    Acta Neurochir (Wien); 2023 May; 165(5):1323-1331. PubMed ID: 36920663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classification of human meningiomas: lights, shadows, and future perspectives.
    Barresi V; Caffo M; Tuccari G
    J Neurosci Res; 2016 Dec; 94(12):1604-1612. PubMed ID: 27376782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of progesterone receptors and P63 to the histological grade of meningiomas: Review and significance in an African population.
    Eluke CC; Aniume OI; Olusina BD; Okafor OC; Olasode BJ
    J Neurosci Rural Pract; 2024; 15(1):69-73. PubMed ID: 38476431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meningioma: A Pathology Perspective.
    Toland A; Huntoon K; Dahiya SM
    Neurosurgery; 2021 Jun; 89(1):11-21. PubMed ID: 33588439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic Characteristics of Grade 2/3 Meningiomas: A Perspective on the Role of Next-Generation Sequencing.
    Kim J; Hwang K; Kwon HJ; Lee JE; Lee KS; Choe G; Han JH; Kim CY
    Front Oncol; 2022; 12():885155. PubMed ID: 35774130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas.
    Combs SE; Schulz-Ertner D; Debus J; von Deimling A; Hartmann C
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1415-21. PubMed ID: 20932661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathodiagnostic parameters and evaluation of O⁶- methyl guanine methyl transferase gene promoter methylation in meningiomas.
    Jabini R; Moradi A; Afsharnezhad S; Ayatollahi H; Behravan J; Raziee HR; Mosaffa F
    Gene; 2014 Apr; 538(2):348-53. PubMed ID: 24398011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.